Capital International Ltd. CA Sells 23,949 Shares of Corteva, Inc. $CTVA

Capital International Ltd. CA lowered its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 9.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 223,024 shares of the company’s stock after selling 23,949 shares during the quarter. Capital International Ltd. CA’s holdings in Corteva were worth $15,083,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in CTVA. Empirical Finance LLC grew its holdings in Corteva by 0.6% during the second quarter. Empirical Finance LLC now owns 24,935 shares of the company’s stock valued at $1,858,000 after purchasing an additional 153 shares during the last quarter. Fox Run Management L.L.C. grew its stake in shares of Corteva by 5.1% in the third quarter. Fox Run Management L.L.C. now owns 3,361 shares of the company’s stock worth $227,000 after acquiring an additional 164 shares during the last quarter. IFG Advisory LLC increased its holdings in shares of Corteva by 1.7% during the 3rd quarter. IFG Advisory LLC now owns 9,764 shares of the company’s stock worth $660,000 after purchasing an additional 166 shares during the period. United Community Bank increased its stake in Corteva by 10.5% during the third quarter. United Community Bank now owns 1,849 shares of the company’s stock valued at $125,000 after acquiring an additional 176 shares during the period. Finally, Binnacle Investments Inc lifted its position in shares of Corteva by 54.7% in the 2nd quarter. Binnacle Investments Inc now owns 512 shares of the company’s stock worth $38,000 after acquiring an additional 181 shares during the period. Institutional investors and hedge funds own 81.54% of the company’s stock.

Insider Activity

In related news, insider Brian Titus sold 8,311 shares of the stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the sale, the insider directly owned 8,090 shares in the company, valued at $619,289.50. This trade represents a 50.67% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 0.15% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the stock. Bank of America lifted their price target on shares of Corteva from $80.00 to $82.00 and gave the stock a “buy” rating in a research note on Thursday, January 8th. Wells Fargo & Company upped their target price on shares of Corteva from $77.00 to $85.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. Jefferies Financial Group raised their price target on shares of Corteva from $85.00 to $95.00 and gave the stock a “buy” rating in a research note on Monday, March 2nd. UBS Group lowered Corteva from a “buy” rating to a “hold” rating in a research note on Monday, February 9th. Finally, Argus raised Corteva to a “strong-buy” rating in a research note on Friday, January 16th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $82.90.

Corteva Stock Up 1.8%

Shares of NYSE CTVA opened at $78.36 on Tuesday. Corteva, Inc. has a 12-month low of $53.40 and a 12-month high of $80.90. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The firm’s 50-day simple moving average is $73.22 and its 200 day simple moving average is $69.04. The company has a market cap of $52.70 billion, a price-to-earnings ratio of 49.59, a price-to-earnings-growth ratio of 2.63 and a beta of 0.72.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.22. The firm had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business’s revenue for the quarter was down 1.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, research analysts expect that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be issued a dividend of $0.18 per share. The ex-dividend date is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio (DPR) is 45.57%.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.